{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:14Z","timestamp":1787021954910,"version":"build-2736575974"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131558","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T14:55:02Z","timestamp":1436194502000},"page":"e0131558","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Chen","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1726-4901(09)70387-9","article-title":"Use of gastroprotective drugs in patients receiving low-dose aspirin","volume":"72","author":"HH Luk","year":"2009","journal-title":"J Chin Med Assoc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3748\/wjg.v18.i24.3167","article-title":"Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications","volume":"18","author":"LL Zhu","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"KC Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin","volume":"103","author":"N Yeomans","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","article-title":"Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial","volume":"46","author":"K Sugano","year":"2011","journal-title":"J Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/hrt.2010.217547","article-title":"Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)","volume":"97","author":"JM Scheiman","year":"2011","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00535-012-0588-x","article-title":"Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial","volume":"47","author":"T Sanuki","year":"2012","journal-title":"J Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"7634","author":"I Forgacs","year":"2008","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.cgh.2007.09.010","article-title":"Use of acid-suppressing drugs and the risk of bacterial gastroenteritis","volume":"5","author":"LA Garcia Rodriguez","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2288-13-82","article-title":"Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs","volume":"13","author":"EN Ramsay","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","article-title":"The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study","volume":"24","author":"LA Fraser","year":"2013","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(09)61246-0","article-title":"Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial","volume":"374","author":"AS Taha","year":"2009","journal-title":"Lancet"},{"key":"ref13","first-page":"CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","volume":"4","author":"A Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","first-page":"b2700","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"21","author":"D Moher","year":"2009","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.gastro.2011.03.049","article-title":"Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy","volume":"141","author":"KJ Lin","year":"2011","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2169\/internalmedicine.48.2031","article-title":"Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting","volume":"48","author":"H Yasuda","year":"2009","journal-title":"Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1186\/1756-0500-6-116","article-title":"Prevalence of gastroduodenal ulcers\/erosions in patients taking low-dose aspirin with either 15 mg\/day of lansoprazole or 40 mg\/day of famotidine: the OITA-GF study 2","volume":"6","author":"A Tamura","year":"2013","journal-title":"BMC Res Notes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.15.727","article-title":"Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin","volume":"15","author":"S Nakashima","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/j.gastro.2010.06.067","article-title":"Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel","volume":"139","author":"CY Wu","year":"2010","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"A Lanas","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref21","first-page":"20","article-title":"Proton pump inhibitors on the antiplatelet function of clopidogrel after coronary artery intervention treatment of acute myocardial infarction patients","volume":"48","author":"Z Wang","year":"2013","journal-title":"Chinese Journal of Medicine"},{"key":"ref22","first-page":"2407","article-title":"Esomeprazole Combined with Rebamipide in Preventing Gastric Mucosal Lesions Induced by Non-steroidal Anti-inflammatory Drugs","volume":"16","author":"XX Tian","year":"2013","journal-title":"Chin Gen Pract"},{"key":"ref23","first-page":"975","article-title":"Analysis of acid-suppressive drug choice after PCI in patients with coronary heart diseases","volume":"22","author":"Y Du","year":"2013","journal-title":"Chin New Drug J"},{"key":"ref24","first-page":"128","article-title":"Efficacy of esomeprazole on gastrointestinal bleeding caused by NSAIDs in the eldery","volume":"25","author":"CY Ji","year":"2011","journal-title":"Pract Geriatr"},{"key":"ref25","unstructured":"Wang Y. Effect of different proton pump inhibitors or H2 receptor antagonists on the anti-platelet functions of clopidogrel in patients after PCI. Thesis, Fourth Military Medical University. 2012."},{"key":"ref26","unstructured":"Wu G. Effect of prognosis of patients with proton pump inhibitors after percutaneous coronary intervention treatment: A retrospective analysis. Thesis, Guang Xi Medical University. 2012."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.3748\/wjg.v16.i42.5342","article-title":"Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy","volume":"16","author":"H Nema","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1443-1661.2011.01176.x","article-title":"Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers","volume":"24","author":"T Sakurada","year":"2012","journal-title":"Dig Endosc"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-230X-12-42","article-title":"Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)","volume":"12","author":"K Sakurai","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jjcc.2008.05.004","article-title":"Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?","volume":"52","author":"S Tanaka","year":"2008","journal-title":"J Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1023\/A:1005652815921","article-title":"Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats","volume":"46","author":"G Sener-Muratoglu","year":"2001","journal-title":"Dig Dis Sci"},{"key":"ref32","first-page":"790","article-title":"PPI vs H2A-Which is stronger inhibitor on acute peptic ulcer bleeding","volume":"22","author":"YZ Cao","year":"2001","journal-title":"J Fourth Mil Med Univ"},{"key":"ref33","first-page":"56","article-title":"High dose proton pump inhibitor and H2 receptor antagonist in the therapy of 86 upper gastrointestinal bleeding patients","volume":"31","author":"M Li","year":"2011","journal-title":"Cli Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12028-010-9397-3","article-title":"Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients","volume":"13","author":"GM Brophy","year":"2010","journal-title":"Neurocrit Care"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3346\/jkms.2010.25.4.583","article-title":"Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study","volume":"25","author":"YJ Kim","year":"2010","journal-title":"J Korean Med Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.2005.02523.x","article-title":"Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status","volume":"22","author":"T Furuta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/clc.22117","article-title":"Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study","volume":"36","author":"Y Arbel","year":"2013","journal-title":"Clin Cardiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12928-012-0123-2","article-title":"Impact of proton pump inhibitors or famotidine on the antiplatelet actions during dual-antiplatelet therapy in Japanese patients","volume":"28","author":"Y Nagata","year":"2013","journal-title":"Cardiovasc Interv Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ahj.2011.08.007","article-title":"Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial","volume":"162","author":"P Tunggal","year":"2011","journal-title":"Am Heart J"},{"key":"ref40","first-page":"1186","article-title":"Comparison of famotidine and rabeprazole on anti-platelet function of clopidogrel in patients with coronary stenting","volume":"42","author":"Y Li","year":"2013","journal-title":"Shaanxi Med J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/0091270010376194","article-title":"Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers","volume":"51","author":"M Nishino","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1939-1676.2010.0651.x","article-title":"Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs","volume":"25","author":"K Tolbert","year":"2011","journal-title":"J Vet Intern Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/j.1440-1746.2006.04270.x","article-title":"Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers","volume":"21","author":"Y Takahashi","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2460\/ajvr.2005.66.425","article-title":"Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs","volume":"66","author":"AM Bersenas","year":"2005","journal-title":"Am J Vet Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.42.2.243","article-title":"Effect of gastric acid suppressants on human gastric motility","volume":"42","author":"HP Parkman","year":"1998","journal-title":"Gut"},{"key":"ref46","first-page":"551","article-title":"Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH","volume":"56","author":"H Iida","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00004836-199506002-00008","article-title":"Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine","volume":"20","author":"M Sakaguchi","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2009.09.063","article-title":"Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions","volume":"138","author":"FH Ng","year":"2010","journal-title":"Gastroenterology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ajg.2011.385","article-title":"Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction","volume":"107","author":"FH Ng","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1253\/circj.CJ-12-0511","article-title":"Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study","volume":"76","author":"H Yano","year":"2012","journal-title":"Circ J"},{"key":"ref51","first-page":"481","article-title":"The clinical effect of esomeprazole in prevention of low dose aspirin induced gastric mucosal injury","volume":"29","author":"M Guo","year":"2009","journal-title":"Chin J Dig"},{"key":"ref52","first-page":"79","article-title":"The effect of rabeprazole in prevention of low-dose aspirin induced gastric mucosal injury in 40 elder patients","volume":"Appl 06","author":"RR Sun","year":"2012","journal-title":"Chin J Mod Drug"},{"key":"ref53","first-page":"114","article-title":"The clinical effect of lansoprazole in prevention of low dose aspirin induced gastric mucosal injury","volume":"24","author":"YP Wang","journal-title":"Strait Pharm J"},{"key":"ref54","first-page":"100","article-title":"The effect of rabeprazole in prevention of low dose aspirin induced gastric mucosal injury","volume":"14","author":"L Hu","year":"2012","journal-title":"MMJC"},{"key":"ref55","first-page":"87","article-title":"Omeprazole affects antiplatelet efficacy of clopidogrel and aspirin after intervention therapy","volume":"40","author":"BJ Lu","year":"2013","journal-title":"Chin J Prac Med"},{"key":"ref56","first-page":"191","article-title":"The efficacy in prevention of upper gastrointestinal injury in patients of acute coronary syndrome with esomeprazole","volume":"10","author":"J Wang","year":"2012","journal-title":"Chin J Card Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"A Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","article-title":"ACCF\/ACG\/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"122","author":"NS Abraham","year":"2010","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1186\/1756-0500-6-116","article-title":"Prevalence of gastroduodenal ulcers\/erosions in patients taking low-dose aspirin with either 15 mg\/day of lansoprazole or 40 mg\/day of famotidine: the OITA-GF study 2","volume":"6","author":"A Tamura","year":"2013","journal-title":"BMC Res Notes"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000141264","article-title":"Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy","volume":"77","author":"FH Ng","year":"2008","journal-title":"Digestion"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"A Lanas","year":"2002","journal-title":"Aliment Pharmacol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T21:19:02Z","timestamp":1566940742000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131558"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131558","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]}}}